Pediatric liquid ‘single tablet regimens’ for HIV—a call to action
- 15 July 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 35 (9), 1497-1498
- https://doi.org/10.1097/qad.0000000000002885
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of ageAIDS, 2021
- Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tabletsJournal of Antimicrobial Chemotherapy, 2009
- TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2004
- Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: A Study of ten casesHuman Pathology, 1985